Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  MRI Interventions, Inc.

BioCorRx Strengthens Intellectual Property Portfolio with Acquisition of Several Patent/Patent Pending Families

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  BIOCORRX, INC.

Integrated Cannabis Company, Inc. to Acquire Assets of Colorado-Based Cannabis Innovator, Critical Mass Industries, LLC, With an Estimated USD $7 Million in Annual Revenue

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Sanofi receives positive CHMP opinion for dengue vaccine

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Aeglea BioTherapeutics to Present Preclinical Data on New Pipeline Therapeutic for Homocystinuria at 2018 American Society of Human Genetics (ASHG) Conference

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Aeglea Biotherapeutics, LLC

Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Principia BioPharma, Inc.

Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Clearside Biomedical, Inc.

Shire plc: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  ShangPharma Corp. (SHP) | Shire plc

Data Safety Monitoring Board Confirms Triple Negative Breast Cancer as the Target Patient Population for Development of NeuVax™ (nelipepimut-S) in Combination with Trastuzumab (Herceptin®) in HER2 1+/2+ Breast Cancer Patients Following Final Analysis

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Next Green Wave Moves to Acquire Six-Time Cannabis Cup Winning Seed Brand as It Nears Completion of Cultivation Facilities -- CFN Media

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Small Stature Scoliosis System with 26th Surgical System

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  OrthoPediatrics Corp.

MediPharm Labs Corp. Bolsters Leadership & Operational Expertise to Further Accelerate Growth

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018

Novartis phase II GEOMETRY mono-1 trial of investigational medicine capmatinib (INC280) shows positive results in patients with MET mutated advanced NSCLC

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Novan, Inc.

Misonix to Report Fiscal 2019 First Quarter Financial Results and Host Conference Call and Webcast on November 8

Read more ››
By: Nasdaq / GlobenewsWire - 19 Oct 2018
Related companies:  Misonix, Inc.

ZincOmega is Now Available at Amazon.com

ISTANBUL, Turkey, Oct. 19, 2018 /PRNewswire/ -- American kids are now fond of fish oil. The omega-3, which is required at all ages, is especially important for children of developmental age. ZincOmega fish oil, which plays an important role in the mental and physical development of children,... Read more ››

By: PR Newswire Association LLC. - 19 Oct 2018
Related companies:  Berko Pharmaceuticals

Hair Loss Expert Lucinda Ellery Reveals Why We Need to Talk About Trichotillomania

NEW YORK, Oct. 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Oct 2018

LGC Capital Ltd. Appoints New Corporate Secretary

MONTREAL, October 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Oct 2018

Seqirus Cell-based Influenza Vaccine Nears European Approval

MAIDENHEAD, England, October 19, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Oct 2018

Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant

ABBOTT PARK, Ill., Oct. 19, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the HeartMate... Read more ››

By: PR Newswire Association LLC. - 19 Oct 2018
Related companies:  Abbott GmbH & Co. KG

Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, Oct. 19, 2018 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523,... Read more ››

By: PR Newswire Association LLC. - 19 Oct 2018
Related companies:  Mylan (UK)
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑